Figure 1.
![PFS based on MRD status (10−5) in MAIA and ALCYONE. Kaplan-Meier estimates of PFS by MRD status among patients in the ITT populations. MRD was assessed at a threshold of 1 tumor cell per 105 white blood cells. Red lines show MRD-negative patient populations and blue lines show MRD-positive patient populations (D-Rd/Rd shown for MAIA [A]; D-VMP/VMP for ALCYONE [B]).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/139/4/10.1182_blood.2020010439/3/bloodbld2020010439f1.png?Expires=1735482696&Signature=Hu1sf3bE6PMTCwT5n2oNbGzxJy8tGHF~8LsDWhpxWNPNtyvdFkiGayALxZEMLt3-SC2dCqK7kp7ZLPfgbqGkIrIBM5OemkLjkVAhJIL75MK0fRZlNIzzKkhDriOOr8i~ACLkv9NZr8omwexvz-A4Thz5iVb9FsXaIvZ3LtvYRXnRJrjShFj9mnI8Fto5LOIUQbV7thtaL6TtfZ9hXasJ8vhrHx~eYyHug5IC0XpkoV~ZuVfKXzclCsq2L9OxDUudj6QYyxhZAZTNg-reXkU0ymcci6fP1q-vBzCu9aVcxgQACRM3pCxplz0cYdLnCXNVz1fSFtywAPHEq1kPBXM3FQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
PFS based on MRD status (10−5) in MAIA and ALCYONE. Kaplan-Meier estimates of PFS by MRD status among patients in the ITT populations. MRD was assessed at a threshold of 1 tumor cell per 105 white blood cells. Red lines show MRD-negative patient populations and blue lines show MRD-positive patient populations (D-Rd/Rd shown for MAIA [A]; D-VMP/VMP for ALCYONE [B]).